Stryker Acquires Inari Medical for $4.9 Billion

Written by: Matthew S. Whitehead

Stryker Corporation (“Stryker”) recently announced that it has entered into a definitive agreement to acquire Inari Medical, Inc. (“Inari”) for approximately $4.9 billion.

Inari develops technologies and products for treating pulmonary embolism, deep vein thrombosis, in-stent thrombosis, and arteriovenous fistula.  Inari’s products include the FlowTriever® Retrieval/Aspiration System, the ClotTriever® Thrombectomy System, the RevCore™ Thrombectomy Catheter, and the InThrill™ Thrombectomy System.  Analysts report that venous thromboembolism is a big market affecting 900,000 people in the United States each year.

Stryker is a global leader in medical technologies, offering medical and surgical equipment and products and services for Neurotechnology and Orthopaedics in about 75 countries which impact more than 150 million patients annually.

Regarding the acquisition, Kevin Lobo, the Chair and Executive Officer of Stryker, stated:

Drew Hykes, the Chief Executive Officer of Inari, stated:

A press release regarding the acquisition is available here.